A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet

NCT02566187 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Hyperlipidemia

Interventions

DRUG: Fimasartan/Atorvastatin Combination Tablet
DRUG: Fimasartan
DRUG: Atorvastatin

Sponsor

Boryung Pharmaceutical Co., Ltd